HARPOON THERAPEUTICS, INC. stock forecast: up to 0.77 USD HARP stock price prognosis


Forecast for Fri 20 Jan 2023 price 1.68

HARPOON THERAPEUTICS, INC. stock price forecast for further price development up to 11.94% (time horizon: 1 day) and price target of 0.77 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) HARPOON THERAPEUTICS, INC. share price prediction for 2023-01-20 with daily closed price projections

Key Facts

Symbol HARP 

ISIN US41358P1066 

CUSIP 41358P106

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

News sentiment (-0.36)

News <--> Close correlation for next day influence (-0.18)

Finance numbers

Revenue 23,154,000.0

Earnings per share -3.43

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

Interim data from this expansion cohort is anticipated by the end of 2021. & & &# 8226; Conventional Manufacturing. We will be responsible for developing HPN217 through a Phase 1/2 clinical trial. 3) Expedite commercial presence and distribution of our products, if approved. Interim data from this expansion cohort is anticipated by the end of 2021.& & In 2018, we completed an IND-enabling, multi-dose GLP toxicology study in animals. One CRS grade 3 occurred in the absence of dexamethasone premedication treatment. Effective treatment options for patients with mesothelioma are very limited. Royalties on net sales will be recognized when the underlying sales occur. For more information, see "Item 3. Below is a summary of how we view our protections and ongoing prosecution efforts.& & An IND must become effective before human clinical trials may begin. These so-called Phase 4 studies may be made a condition to approval of the BLA. The BPCIA is complex and continues to be interpreted and implemented by the FDA. As of February 28, 2021, we had 78 full-time employees. Further, new studies may change the estimated incidence or prevalence of these cancers. We may not be able to build an effective sales and marketing organization. In addition, there is a natural transition period when a new CRO commences work. We may not be able to negotiate collaborations on acceptable terms, or at all. We rely on third-party manufacturers to produce our product candidates. We may license our trademarks and trade names to third parties, such as distributors. Such an outcome could have a material adverse effect on our business. This applies to all of our U.S. patents, even those issued before March 16, 2013. Cyber threats may be generic, or they may be targeted against our information systems. Item 1B. Unresolved Staff Comments Not applicable.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1708493/000156459021012063/0001564590-21-012063.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 34.72/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
ORBIMED ADVISORS LLC 2021-03-31 2285704
STRS OHIO 2021-06-30 25600

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2021-05-31 34224 Long
SPARROW FUNDS 2021-05-31 38875 Long
Fidelity Salem Street Trust 2021-04-30 104945 Long
Fidelity Concord Street Trust 2021-04-30 3937 Long
iShares Trust 2021-04-30 8107 Long

Bollinger Bollinger Bands for HARPOON THERAPEUTICS, INC. can provide the information where the market is moving based on price information.

HARPOON THERAPEUTICS, INC. Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

On-Balance Volume information for HARPOON THERAPEUTICS, INC.. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for HARPOON THERAPEUTICS, INC.. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for HARPOON THERAPEUTICS, INC.. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for HARPOON THERAPEUTICS, INC.. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for HARPOON THERAPEUTICS, INC.. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for HARPOON THERAPEUTICS, INC.. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for HARPOON THERAPEUTICS, INC.. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2022-11-30 0.77 2022-11-26 03:08
2022-12-01 0.79 2022-11-26 03:08
2022-12-02 0.82 2022-11-26 03:08
2022-12-05 0.83 2022-11-26 03:08
2022-12-06 0.86 2022-11-26 03:08
2022-12-07 0.89 2022-11-26 03:08
2022-12-08 0.91 2022-11-26 03:08
2022-12-09 0.94 2022-11-26 03:08
2022-12-12 0.96 2022-11-26 03:08
2022-12-13 0.97 2022-11-26 03:08
2022-12-14 0.99 2022-11-26 03:08
2022-12-15 1.01 2022-11-26 03:08
2022-12-16 1.03 2022-11-26 03:08
2022-12-19 1.05 2022-11-26 03:08
2022-12-20 1.08 2022-11-26 03:08
2022-12-21 1.10 2022-11-26 03:08
2022-12-22 1.13 2022-11-26 03:08
2022-12-23 1.16 2022-11-26 03:08
2022-12-26 1.19 2022-11-26 03:08
2022-12-27 1.21 2022-11-26 03:08
2022-12-28 1.24 2022-11-26 03:08
2022-12-29 1.27 2022-11-26 03:08
2022-12-30 1.29 2022-11-26 03:08
2023-01-02 1.32 2022-11-26 03:08
2023-01-03 1.35 2022-11-26 03:08
2023-01-04 1.37 2022-11-26 03:08
2023-01-05 1.39 2022-11-26 03:08
2023-01-06 1.42 2022-11-26 03:08
2023-01-09 1.45 2022-11-26 03:08
2023-01-10 1.47 2022-11-26 03:08
2023-01-11 1.50 2022-11-26 03:08
2023-01-12 1.52 2022-11-26 03:08
2023-01-13 1.55 2022-11-26 03:08
2023-01-16 1.57 2022-11-26 03:08
2023-01-17 1.60 2022-11-26 03:08
2023-01-18 1.63 2022-11-26 03:08
2023-01-19 1.65 2022-11-26 03:08
2023-01-20 1.68 2022-11-26 03:08